VisiCELL Medical Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

VisiCELL Medical Inc., “GPS for Cell Therapy”, is developing in vivo imaging analytics for customers with cell-based therapies in solid tumor cancers, autoimmune diseases and regenerative medicine in the multi-billion dollar cell and gene therapy industry.  
Visicell’s patented, disruptive technology provides real time imaging insights over time of cell therapies within disease contexts in animals and human patients by standard Magnetic Resonance Imaging (MRI) overcoming the current practical limitations of painful biopsy, single time-point histopathology and noisy PCR, where tissue sample scarcity and inaccessible disease locations are additional obstacles to data collection for informed decision-making. The pharmacokinetic, pharmacodynamic, safety and efficacy information acquired in a longitudinal, repeatable fashion in both preclinical and clinical settings enable faster and more accurate actionable decision-making for improved outcomes. It seamlessly integrates into existing disease response monitoring workflows, such as cancer, neurodegenerative or cardiovascular monitoring. 
This benefits the cell therapy companies with accelerated product development, shortened time to market and improved outcomes thereby creating competitive advantage and economic value. We are revenue generating, have signed a research collaboration agreement with a large pharma, and are in deep discussion with multiple cell therapy developers for early technology assessment and strategic partnerships for long-term mutual value creation opportunities.

Sign up for free to view info

Email Format Employee directory